Pressroom: Media Coverage

Showing 421 - 440 of 598 news items

2012

Meaning-Based Therapy May Aid Terminal Patient

Psychiatry Service Chief William Breitbart discussed his study that found that talk therapy sessions focused on spirituality and finding meaning improved quality of life and well-being in terminally ill cancer patients. Dr. Breitbart said, “What’s critical for cancer patients is for them to understand that even with advanced cancer, there is always the possibility for the experience of meaning, even in the last days of life.”

March 2, 2012
“Chemobrain” May Linger 20 Years after Breast Cancer Treatment

New research suggests that “chemobrain,” the name given to the mental fog and related memory problems that can occur during and after chemotherapy, may last for two decades after breast cancer treatment. Psychologist Tim Ahles said the new study is the first to illustrate that long-term breast cancer survivors still experience difficulty with their thought processes.

February 27, 2012
Report Affirms Lifesaving Role of Colonoscopy

A new study led by epidemiologist Ann Zauber and gastroenterologist Sidney Winawer found that removing polyps by colonoscopy not only prevents colorectal cancer from developing, but also prevents deaths from the disease. Although many people have assumed that colonoscopy must save lives because it is so often recommended, strong evidence has been lacking until now.

February 23, 2012
New Hospital Cuisine: Dishes Made to Order

Chemotherapy can dramatically affect a patient’s appetite, tastes, and diet. Executive Chef Pnina Peled talked about a growing trend among hospitals to revamp their kitchens and offer more-personalized menu items for patients with a variety of nutritional needs. Food and Nutrition Services Director Veronica McLymont was also quoted.

February 21, 2012
Clinical Trials Network Aims to Strengthen Cancer Immunotherapy Pipeline

Medical oncologist Jedd Wolchok spoke about a new initiative called the Cancer Immunotherapy Trials Network (CITN). Dr. Wolchok is one of 27 researchers chosen from the nation’s top cancer centers and universities to lead clinical trials to spur the development of cancer treatments that work by revving up the immune system’s response to tumors.

February 21, 2012
What's the Cure in the Race against Breast Cancer?

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton was interviewed about prevention and treatment innovations for breast cancer patients. He said, “There are a lot of very exciting things that are moving forward, and it’s all based on a new understanding of the biology of cancer.”

NPR
February 19, 2012
Fake Cancer Drug Found in US

Gastrointestinal Oncology Acting Chief Leonard Saltz spoke about a counterfeit version of Avastin found in the United States. Counterfeiting has historically been more of a problem outside the US, and experts say counterfeits are a relatively small but still serious problem for the nation’s drug supply. Avastin is a commonly used drug for patients with colon, lung, and other cancers.

February 15, 2012
Rare Mutations Tied to Breast, Pancreatic Cancers

The inherited genetic mutations that can lead to Lynch syndrome may put people at extra risk for breast and pancreatic cancer, in addition to their well-known ties to colon and endometrial cancers, a new report found. Pathologist Jinru Shia was quoted.

February 15, 2012
Livingston Cancer Victim Lives On through Cycling Fundraiser

Memorial Sloan Kettering patient Jennifer Goodman Linn co-founded Cycle for Survival, an indoor cycling event that started as a single-gym fundraiser with a five-figure goal but has now raised more than $14 million for cancer research. Her oncologist, Gary Schwartz, was quoted.

February 10, 2012
Girl Riddled with Cancer Tumors Now in Remission after Pioneering Treatment in US

8H9, a promising new treatment that targets neuroblastoma cells, is helping two-year-old Lilly MacGlashan beat cancer. Lilly’s pediatric oncologist, Kim Kramer, said, “We have made great progress and have treated plenty of children who have beaten this and gone on to live good lives without the cancer coming back anywhere in their bodies.”

February 7, 2012
Daughter Diagnosed with Leukemia Inspires Father to Ride

Christopher Sarro, whose daughter was diagnosed with leukemia last year, is participating in this year’s Cycle for Survival to raise funds for cancer research at Memorial Sloan Kettering. The indoor cycling event, co-founded in 2007 by Jennifer Goodman Linn, who lost her battle with cancer last year, is Memorial Sloan Kettering’s most successful patient-run fundraiser to date. Ms. Linn’s oncologist, Gary Schwartz, was quoted.

February 6, 2012
Experimental Drug Shows Promising Results for Men with Prostate Cancer

Memorial Sloan Kettering patient John O’Mara and his oncologist, Daniel Danila, spoke about the investigational oral drug MDV3100, which is improving outcomes in patients with advanced prostate cancer. Mr. O’Mara, a clinical trial subject who is receiving the drug, said, “I do look at the future, even though I’m quite an old man, with a great deal more confidence.”

NY1
February 6, 2012
The Cure for the Common Hospital

Pediatric oncologist Kim Kramer talked about life in the pediatrics department and what makes Memorial Sloan Kettering unique from other cancer treatment centers.

February 3, 2012
Gaining on Prostate Cancer

The investigational oral drug MDV3100 significantly improved overall survival in patients with advanced prostate cancer, according to results presented by lead investigator Howard Scher at a recent medical meeting. Lab work conducted by Charles Sawyers and colleagues was instrumental in the development of this novel therapy.

January 31, 2012
Breast Cancer Surgery Rules Are Called Unclear

Breast Surgical Chief Monica Morrow said that a new study might help push professional groups to develop guidelines for lumpectomy surgery, the most common operation to treat breast cancer. According to the study, nearly half of women who had lumpectomies for breast cancer had second operations they may not have needed.

January 31, 2012
Catch Me If You Can

Infectious disease specialist Kent Sepkowitz authored this opinion on cancer screening tests. Enthusiasm for routine mammography and PSA screening has waned recently, as the US Preventive Services Task Force has changed its recommendations for such screening measures. “Perhaps what is lacking,” Dr. Sepkowitz said, “is a respect for the calm pace required for true innovation.”

January 30, 2012
Pricey Surgery Robots Lack Clear Benefits

Gynecologic oncologist Mario Leitao argued that doctors shouldn’t give up on robots despite a new study that found similar complication rates among women treated for endometrial cancer with robotic surgery versus traditional laparoscopy.

January 30, 2012
Cycle Event Raises Funds, Honors Cancer Patient

Memorial Sloan Kettering patient Jennifer Goodman Linn co-founded Cycle for Survival, an annual cycling event to raise awareness for rare cancers. Katie Kotkins, who heads the initiative, said that more than $12 million has been raised since the organization’s inception.

January 25, 2012
Americans: Nursing Most Honest, Ethical Profession

When asked which profession they think is the most honest and ethical, Americans rank nursing No. 1. Nurses consistently have topped Gallup’s annual poll since the profession was first included in 1999. Ann Culkin, a nurse on the Thoracic Oncology Service, weighed in on why she believes nursing is so trusted by Americans.

January 23, 2012
Adolescents More Likely to Ignore Sun Protection As They Age

Epidemiologist Stephen Dusza led a study that found that most children do not regularly use sunscreen. Dr. Dusza and his team of investigators surveyed 360 fifth graders over three years and found that half of the children who routinely used sunscreen at the beginning of the study no longer did so three years later.

January 23, 2012